Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32101
Title: Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?
Austin Authors: Klein, Oliver ;Kee, Damien ;Nagrial, Adnan;Markman, Ben;Underhill, Craig;Michael, Michael;Behren, Andreas;Palmer, Jodie ;Tebbutt, Niall C ;Carlino, Matteo S;Cebon, Jonathan S 
Affiliation: Medical Oncology
Blacktown Hospital, Blacktown, New South Wales, Australia.
Department of Medical Oncology, Alfred Health, Prahran, Victoria, Australia.
Albury-Wodonga Regional Cancer Centre, Albury-Wodonga, New South Wales, Australia.
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Olivia Newton-John Cancer Research Institute
Blacktown Hospital, Blacktown, New South Wales, Australia.
Issue Date: 1-Apr-2023
Date: 2023
Publication information: Cancer 2023-04-01; 129(7)
URI: https://ahro.austin.org.au/austinjspui/handle/1/32101
DOI: 10.1002/cncr.34660
ORCID: 0000-0003-0022-9553
Journal: Cancer
Start page: 1129
End page: 1130
PubMed URL: 36692958
ISSN: 1097-0142
Type: Journal Article
Subjects: Antibodies, Monoclonal/therapeutic use
Appears in Collections:Journal articles

Show full item record

Page view(s)

62
checked on Jun 16, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.